The association between restless leg syndrome and anxiety in Parkinson’s disease: a case-control study

References

• Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386(9996):896–912.
   PubMed Web of Science ®Google Scholar
• Samii A, Nutt JG, Ransom BR. Parkinson’s disease. Lancet. 2004;363(9423):1783–1793.
   PubMed Web of Science ®Google Scholar
• Rana AQ, Kabir A, Jesudasan M, et al. Pain in Parkinson’s disease: analysis and literature review. Clin Neurol Neurosurg. 2013;115(11):2313–2317.
   PubMed Web of Science ®Google Scholar
• Rana A, Saeed U, Masroor MS, et al. A cross-sectional study investigating clinical predictors and physical experiences of pain in Parkinson’s disease. Funct Neurol. 2013;28(4):297–304.
   PubMedGoogle Scholar
• Shulman LM, Taback RL, Bean J, et al. Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord. 2001;16(3):507–510.
   PubMed Web of Science ®Google Scholar
• Pontone GM, Williams JR, Anderson KE, et al. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson’s disease. Mov Disord. 2009;24(9):1333–1338.
   PubMed Web of Science ®Google Scholar
• Leentjens AF, Dujardin K, Marsh L, et al. Anxiety rating scales in Parkinson’s disease: critique and recommendations. Mov Disord. 2008;23(14):2015–2025.
   PubMed Web of Science ®Google Scholar
• D’Iorio A, Vitale C, Piscopo F, et al. Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson’s disease. Parkinsonism Relat Disord. 2017;43:114–117.
   PubMed Web of Science ®Google Scholar
• Landau S, Harris V, Burn DJ, et al. Anxiety and anxious-depression in Parkinson’s disease over a 4-year period: a latent transition analysis. Psychol Med. 2016;46(3):657–667.
   PubMed Web of Science ®Google Scholar
• Corcos DM, Robichaud JA, David FJ, et al. A two-year randomized controlled trial of progressive resistance exercise for Parkinson’s disease. Mov Disord. 2013;28(9):1230–1240.
   PubMed Web of Science ®Google Scholar
• Garcia-Borreguero D, Egatz R, Winkelmann J, et al. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev. 2006;10(3):153–167.
   PubMed Web of Science ®Google Scholar
• Szentkiralyi A, Madarasz CZ, Novak M. Sleep disorders: impact on daytime functioning and quality of life. Expert Rev Pharmacoecon Outcomes Res. 2009;9(1):49–64.
   PubMedGoogle Scholar
• Jahani KM, Kolla BP, Moore KM, et al. Management of restless legs syndrome in pregnancy and lactation. J Prim Care Community Health. 2020;11:2150132720905950.
   Web of Science ®Google Scholar
• Heidbreder A, Stefani A, Mitterling T, et al. Do periodic leg movements differ between restless legs syndrome patients with low versus normal iron stores? Sleep Med. 2017;32:271.
   PubMed Web of Science ®Google Scholar
• Ediz L, Hiz O, Toprak M, et al. Restless legs syndrome in Behcet’s disease. J Int Med Res. 2011;39(3):759–765.
   PubMed Web of Science ®Google Scholar
• Piao YS, Lian T-H, Hu Y, et al. Restless legs syndrome in Parkinson disease: clinical characteristics, abnormal iron metabolism and altered neurotransmitters. Sci Rep. 2017;7(1):10547.
   PubMed Web of Science ®Google Scholar
• Alonso-Navarro H, García-Martín E, Agúndez JAG, et al. Association between restless legs syndrome and other movement disorders. Neurology. 2019;92(20):948–964.
   PubMed Web of Science ®Google Scholar
• Rana AQ, Siddiqui, I, Mosabbir, A, et al. Association of pain, Parkinson’s disease, and restless legs syndrome. J Neurol Sci. 2013;327(1–2):32–34.
   PubMed Web of Science ®Google Scholar
• Gulyani S, Salas R, Mari Z, et al. Evaluating and managing sleep disorders in the Parkinson’s disease clinic. Basal Ganglia. 2016;6(3):165–172.
   PubMed Web of Science ®Google Scholar
• Yang X, Liu B, Shen H, et al. Prevalence of restless legs syndrome in Parkinson’s disease: a systematic review and meta-analysis of observational studies. Sleep Med. 2018;43:40–46.
   PubMed Web of Science ®Google Scholar
• Trenkwalder C, Allen R, Högl B, et al. Restless legs syndrome associated with major diseases: a systematic review and new concept. Neurology. 2016;86(14):1336–1343.
   PubMed Web of Science ®Google Scholar
• Cederberg K, Jeng B, Sasaki JE, et al. Restless legs syndrome and health-related quality of life in adults with multiple sclerosis. J Sleep Res. 2020;29(3):e12880.
   PubMed Web of Science ®Google Scholar
• Merlino G, Valente M, Serafini A, et al. Effects of restless legs syndrome on quality of life and psychological status in patients with type 2 diabetes. Diabetes Educ. 2010;36(1):79–87.
   PubMed Web of Science ®Google Scholar
• Ostacoli L, Saini A, Ferini-Strambi L, et al. Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy. Qual Life Res. 2010;19(4):531–537.
   PubMed Web of Science ®Google Scholar
• Seferoğlu M, Sivaci AÖ, Tunç A. Restless legs syndrome/Willis-Ekbom disease in multiple sclerosis: a contributing factor for anxiety, disability, sleep disorder, and quality of life. Arq Neuropsiquiatr. 2020;78(11):708–712.
   PubMed Web of Science ®Google Scholar
• Rana AQ, Mosabbir AA, Qureshi ARM, et al. Restless leg syndrome: a risk factor of higher prevalence of anxiety and depression in Parkinson’s disease patients. Neurol Res (New York). 2016;38(4):309–312.
   Web of Science ®Google Scholar
• Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–1601.
   PubMed Web of Science ®Google Scholar
• Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria–history, rationale, description, and significance. Sleep Med. 2014;15(8):860–873.
   PubMed Web of Science ®Google Scholar
• Tully PJ, Kurth T, Elbaz A, et al. Convergence of psychiatric symptoms and restless legs syndrome: a cross-sectional study in an elderly French population. J Psychosom Res. 2020;128:109884.
   PubMed Web of Science ®Google Scholar
• Rizzo G, Manners, D, Testa, C, et al. Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging. Mov Disord. 2013;28(13):1886–1890.
   PubMed Web of Science ®Google Scholar
• Connor JR Wang, XS, and Allen, RP, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain. 2009;132:2403–2412.
   PubMed Web of Science ®Google Scholar
• Rana AQ, Qureshi ARM, Rahman L, et al. Association of restless legs syndrome, pain, and mood disorders in Parkinson’s disease. Int J Neurosci. 2016;126(2):116–120.
   PubMed Web of Science ®Google Scholar
• Femenia T, Qian Y, Arentsen T, et al. Toll-like receptor-4 regulates anxiety-like behavior and DARPP-32 phosphorylation. Brain Behav Immun. 2018;69:273–282.
   PubMed Web of Science ®Google Scholar
• Perez-Pardo P, Dodiya HB, Engen PA, et al. Role of TLR4 in the gut-brain axis in Parkinson’s disease: a translational study from men to mice. Gut. 2019;68(5):829–843.
   PubMed Web of Science ®Google Scholar